Clinical Trials · NCT00872378
The Effects of Exenatide After Gastric Restriction
- Phase
- Phase 2/Phase 3
- Recruitment status
- Unknown
- Sponsor
- Advanced Specialty Care
- Enrollment
- 28
- Start date
- Feb 2009
- Locations
- 2 sites, United States
- Primary endpoint
- To describe change in body weight in non-diabetic morbidly obese patients after laparoscopic adjustable gastric banding (LAGB) with twice daily exenatide plus lifestyle modification plan or placebo plus lifestyle modification plan.